BXP154

· Bio 54, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BXP154, covering 2024-07-29 to 2024-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154 [Phase 2]